Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 208

1.

Epigenetic dysregulation of host gene expression in Toxoplasma infection with specific reference to dopamine and amyloid pathways.

Syn G, Anderson D, Blackwell JM, Jamieson SE.

Infect Genet Evol. 2018 Jul 26;65:159-162. doi: 10.1016/j.meegid.2018.07.034. [Epub ahead of print]

PMID:
30055328
2.

Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection.

Hamdani N, Bengoufa D, Godin O, Doukhan R, Le Guen E, Daban-Huard C, Bennabi M, Delavest M, Lépine JP, Boukouaci W, Laouamri H, Houenou J, Jamain S, Richard JR, Lecorvosier P, Yolken R, Rajagopal K, Leboyer M, Tamouza R.

BMC Psychiatry. 2018 Jul 27;18(1):239. doi: 10.1186/s12888-018-1821-9.

3.

The potential risk of toxoplasmosis for traffic accidents: A systematic review and meta-analysis.

Gohardehi S, Sharif M, Sarvi S, Moosazadeh M, Alizadeh-Navaei R, Hosseini SA, Amouei A, Pagheh A, Sadeghi M, Daryani A.

Exp Parasitol. 2018 Aug;191:19-24. doi: 10.1016/j.exppara.2018.06.003. Epub 2018 Jun 12. Review.

PMID:
29906469
4.

Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Xiao J, Prandovszky E, Kannan G, Pletnikov MV, Dickerson F, Severance EG, Yolken RH.

Schizophr Bull. 2018 Jun 8. doi: 10.1093/schbul/sby082. [Epub ahead of print]

PMID:
29889280
5.

Immunological Characteristics of Schizophrenia.

Rubesa G, Gudelj L, Makovac D.

Psychiatr Danub. 2018 Jun;30(Suppl 4):180-187.

6.

Serological and molecular diagnosis of Toxoplasma gondii in patients with schizophrenia.

Ebrahimzadeh A, Shahraki MK, Mohammadi A.

J Parasit Dis. 2018 Jun;42(2):177-181. doi: 10.1007/s12639-018-0979-x. Epub 2018 Mar 8.

PMID:
29844620
7.

Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort.

Fond G, Boyer L, Schürhoff F, Berna F, Godin O, Bulzacka E, Andrianarisoa M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Dubreucq J, Faget C, Lançon C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Llorca PM, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, Andrianarisoa M, Aouizerate B, Bazin N, Berna F, Blanc O, Brunel L, Bulzacka E, Capdevielle D, Chereau-Boudet I, Chesnoy-Servanin G, Coulon N, Danion JM, D'Amato T, Deloge A, Denizot H, Dorey JM, Dubertret C, Dubreucq J, Faget C, Fluttaz C, Fond G, Fonteneau S, Gabayet F, Giraud-Baro E, Jarroir M, Leignier S, Lacelle D, Lançon C, Laouamri H, Leboyer M, Le Gloahec T, Le Strat Y, Llorca PM, Mallet J, Metairie E, Misdrahi D, Offerlin-Meyer I, Passerieux C, Peri P, Pires S, Portalier C, Ramet L, Rey R, Roman C, Schandrin A, Schürhoff F, Tessier A, Tronche AM, Urbach M, Vaillant F, Vehier A, Vidailhet P, Vilà E, Yazbek H, Zinetti-Bertschy A.

Schizophr Res. 2018 May 27. pii: S0920-9964(18)30265-2. doi: 10.1016/j.schres.2018.05.007. [Epub ahead of print]

PMID:
29843964
8.

SEROPREVALENCE AND RISK FACTOR OF TOXOPLASMOSIS IN SCHIZOPHRENIA PATIENTS REFERRED TO GRHASIA PSYCHIATRIC HOSPITAL, YOGYAKARTA, INDONESIA.

Muflikhah ND, Supargiyono, Artama WT.

Afr J Infect Dis. 2018 Mar 7;12(1 Suppl):76-82. doi: 10.2101/Ajid.12v1S.11. eCollection 2018.

9.

HLA typing using genome wide data reveals susceptibility types for infections in a psychiatric disease enriched sample.

Parks S, Avramopoulos D, Mulle J, McGrath J, Wang R, Goes FS, Conneely K, Ruczinski I, Yolken R, Pulver AE, Pearce BD.

Brain Behav Immun. 2018 May;70:203-213. doi: 10.1016/j.bbi.2018.03.001. Epub 2018 Mar 21.

PMID:
29574260
10.

Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.

Sagud M, Vlatkovic S, Svob Strac D, Sviben M, Zivkovic M, Vilibic M, Vuksan-Cusa B, Mihaljevic-Peles A, Pivac N.

Compr Psychiatry. 2018 Apr;82:115-120. doi: 10.1016/j.comppsych.2018.02.002. Epub 2018 Feb 12.

PMID:
29477703
11.

Clinical and Serological Predictors of Suicide in Schizophrenia and Major Mood Disorders.

Dickerson F, Origoni A, Schweinfurth LAB, Stallings C, Savage CLG, Sweeney K, Katsafanas E, Wilcox HC, Khushalani S, Yolken R.

J Nerv Ment Dis. 2018 Mar;206(3):173-178. doi: 10.1097/NMD.0000000000000772.

PMID:
29474231
12.

What causes psychosis? An umbrella review of risk and protective factors.

Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, Yenn Thoo H, Oliver D, Davies C, Morgan C, McGuire P, Murray RM, Fusar-Poli P.

World Psychiatry. 2018 Feb;17(1):49-66. doi: 10.1002/wps.20490.

13.

Seroprevalence and Manifestations of Ocular Toxoplasmosis in Patients with Schizophrenia.

Morais FB, Arantes TEFE, Muccioli C.

Ocul Immunol Inflamm. 2017 Dec 28:1-4. doi: 10.1080/09273948.2017.1408843. [Epub ahead of print]

PMID:
29283732
14.

An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection.

Fallahi S, Rostami A, Nourollahpour Shiadeh M, Behniafar H, Paktinat S.

J Gynecol Obstet Hum Reprod. 2018 Mar;47(3):133-140. doi: 10.1016/j.jogoh.2017.12.003. Epub 2017 Dec 8. Review.

PMID:
29229361
15.

Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia.

Yolken R, Torrey EF, Dickerson F.

PLoS Negl Trop Dis. 2017 Nov 6;11(11):e0006040. doi: 10.1371/journal.pntd.0006040. eCollection 2017 Nov.

16.

Relationship between toxoplasmosis and schizophrenia: A review.

Fuglewicz AJ, Piotrowski P, Stodolak A.

Adv Clin Exp Med. 2017 Sep;26(6):1031-1036. doi: 10.17219/acem/61435. Review.

17.
18.

Increased prevalence of Toxoplasma gondii seropositivity in patients with treatment-resistant schizophrenia.

Vlatkovic S, Sagud M, Svob Strac D, Sviben M, Zivkovic M, Vilibic M, Vuksan-Cusa B, Mihaljevic-Peles A, Pivac N.

Schizophr Res. 2018 Mar;193:480-481. doi: 10.1016/j.schres.2017.08.006. Epub 2017 Aug 9. No abstract available.

PMID:
28802819
19.

Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia.

Kannan G, Gressitt KL, Yang S, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CLG, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Bahn S, Leweke FM, Dickerson FB, Yolken RH, Pletnikov MV, Severance EG.

Transl Psychiatry. 2017 Aug 1;7(8):e1186. doi: 10.1038/tp.2017.162.

20.

Seroepidemiological Study of Toxoplasma gondii Infection among Psychiatric Patients in Mashhad, Northeast of Iran.

Abdollahian E, Shafiei R, Mokhber N, Kalantar K, Fata A.

Iran J Parasitol. 2017 Jan-Mar;12(1):117-122.

Supplemental Content

Loading ...
Support Center